Difficulty: Medium
Average Score: 91%
Practice
The diuretic of choice for the initial treatment of a patient with either acute or chronic renal failure (ARF, CRF) whose creatinine clearance is below 25 ml/min is
Correct answer
C
Rationale
In the context of treating a patient with acute or chronic renal failure (ARF, CRF) and a creatinine clearance below 25 ml/min, the diuretic of choice is furosemide (Option C). Furosemide is a loop diuretic that acts on the thick ascending loop of Henle in the kidney to inhibit sodium and chloride reabsorption, promoting diuresis.
Furosemide is preferred in renal failure as it works despite reduced renal function by acting on the loop of Henle, which is typically not as affected in renal failure compared to other segments of the nephron. This makes it more effective in patients with compromised kidney function.
Hydrochlorothiazide (Option A) is a thiazide diuretic that acts on the distal convoluted tubule and is less effective in patients with reduced renal function. Bumetanide (Option B) is a loop diuretic similar to furosemide but may not be as well-tolerated in renal failure patients. Ethacrynic acid (Option D) is another loop diuretic but is less commonly used due to its side effect profile and availability of other options.
In an educational context, understanding the mechanisms of action and pharmacokinetics of diuretics is crucial in selecting the appropriate agent for patients with renal impairment. This knowledge helps healthcare providers make informed decisions to optimize therapeutic outcomes while minimizing adverse effects.
Furosemide is preferred in renal failure as it works despite reduced renal function by acting on the loop of Henle, which is typically not as affected in renal failure compared to other segments of the nephron. This makes it more effective in patients with compromised kidney function.
Hydrochlorothiazide (Option A) is a thiazide diuretic that acts on the distal convoluted tubule and is less effective in patients with reduced renal function. Bumetanide (Option B) is a loop diuretic similar to furosemide but may not be as well-tolerated in renal failure patients. Ethacrynic acid (Option D) is another loop diuretic but is less commonly used due to its side effect profile and availability of other options.
In an educational context, understanding the mechanisms of action and pharmacokinetics of diuretics is crucial in selecting the appropriate agent for patients with renal impairment. This knowledge helps healthcare providers make informed decisions to optimize therapeutic outcomes while minimizing adverse effects.